ClinicalTrials.Veeva

Menu

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos (CuidaTEXT R01)

University of Kansas logo

University of Kansas

Status

Enrolling

Conditions

Alzheimer Disease

Treatments

Behavioral: CuidaTEXT

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06728436
1R01AG082306 (U.S. NIH Grant/Contract)
150585

Details and patient eligibility

About

The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos.

Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences .

Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.

Enrollment

288 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Over the age of 18
  • Spanish and English-speaking people who identify as Latino
  • Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment
  • Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
  • Self-reports being able to read and write
  • Owns a cell phone with a flat fee, and uses it at least weekly for texting.

Exclusion criteria

  • Participation in another wellbeing-related clinical trial
  • Cohabitation with another participant in the CuidaTEXT R01 Study
  • Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study
  • Participant plans to move to another country within seven months

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

288 participants in 2 patient groups

CuidaTEXT
Experimental group
Description:
6 months of CuidaTEXT intervention + 1-month post-treatment
Treatment:
Behavioral: CuidaTEXT
7-Month Waitlist Control
No Intervention group
Description:
Participants allocated to this arm will be offered the opportunity to start CuidaTEXT immediately after their 7 Month follow-up assessment

Trial contacts and locations

1

Loading...

Central trial contact

Rachel Ruiz; Jaime Perales Puchalt, PhD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems